Shanghai MAaGI Medical Technology Co., Ltd. was established in 2016 by an innovation team from Shanghai Jiao Tong University. Leveraging its multi-year independently developed multimodal thermophysical technology, the company has deeply cultivated the field of tumor treatment and is committed to spearheading the advancement of innovative tumor therapies.
Headquartered at the Caohejing International Incubation Center, the company boasts a full-chain R&D platform that integrates fundamental research, technological innovation, and clinical translation. Its production base, covering an area of 900 square meters, features a Class 100,000 purification workshop and a microbiology laboratory, endowing it with the capacity for the independent production of equipment and a full range of supporting sterile consumables.
The company has jointly established the Multimodal Thermophysical Immunotherapy Joint Laboratory with Shanghai Jiao Tong University to explore the application of cutting-edge thermophysical immunotherapy technologies. It has received support from multiple national programs, including the Ministry of Science and Technology's Major Project for Digital Diagnosis and Treatment and the Special Project of Zhangjiang National Independent Innovation Demonstration Zone.
The company has forged close partnerships with top-tier hospitals in the field of tumor treatment, such as the Fudan University Shanghai Cancer Center. Together, they have completed research on clinical solutions, including the first batch of major national research projects for digital healthcare by the Ministry of Science and Technology, and have published the Expert Consensus on Multimodal Tumor Treatment.
MAaGI Medical, in collaboration with the Chinese Society of Biomedical Engineering and numerous renowned hospitals, jointly initiated the establishment of the Innovation and Transformation Consortium for Multimodal Minimally Invasive Diagnosis and Treatment Technology of Tumors. This initiative effectively drives the innovation and clinical application of multimodal tumor treatment technologies, serves the vast population of oncology patients, and has earned widespread recognition for its clinical value.
MAaGI Medical and Shanghai Jiao Tong University have established the SJTU School of Biomedical Engineering – MAaGI Medical Joint Laboratory for Multimodal Thermophysical Immunotherapy. By fully integrating multidisciplinary expertise, the laboratory continuously advances research in multimodal thermophysical ablation immunotherapy for tumors
MAaGI Medical adheres to interdisciplinary innovation and research, receiving supports from key national projects.
Clinical Solution Research on Image‑Guided Multimodal Ablation Therapy for Solid Tumors
Study on Thermophysical Issues in Clinical Tumor Cryo‑Hyperthermia Therapy
Shanghai Engineering Research Center for High‑End Medical Diagnosis and Treatment Equipment and Technology
Shanghai Med‑X Engineering Technology Research Center for Physical Therapy and Detection Equipment for Major Diseases
Innovation and Demonstration of Original Tumor Early Screening and Immunotherapy Technology
Multimodal Tumor Radiofrequency Therapy System Admitted into the “Innovative Medical Devices” Special Approval Process
